Cite

HARVARD Citation

    Brioli, A. et al. (n.d.). Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma. Leukemia & lymphoma. 54 (9), pp. 1975-1981. [Online]. 
  
Back to record